cis-ccc_R08
|
C650286-5mg
|
≥99% |
2413192-48-8 |
5mg
|
¥ 6200.9
|
期货,请咨询 |
阿拉丁 |
cis-ccc_R08
|
C650286-1mg
|
≥99% |
2413192-48-8 |
1mg
|
¥ 2400.9
|
期货,请咨询 |
阿拉丁 |
cis-ccc_R08
|
C650286-10mg
|
≥99% |
2413192-48-8 |
10mg
|
¥ 10000.9
|
期货,请咨询 |
阿拉丁 |
Cinitapride
|
C650260-5mg
|
|
66564-14-5 |
5mg
|
¥ 2000.9
|
期货,请咨询 |
阿拉丁 |
Cinitapride
|
C650260-50mg
|
|
66564-14-5 |
50mg
|
¥ 10200.9
|
期货,请咨询 |
阿拉丁 |
Cinitapride
|
C650260-25mg
|
|
66564-14-5 |
25mg
|
¥ 6400.9
|
期货,请咨询 |
阿拉丁 |
Cinitapride
|
C650260-10mg
|
|
66564-14-5 |
10mg
|
¥ 3200.9
|
期货,请咨询 |
阿拉丁 |
CCR8 antagonist 2
|
C650241-5mg
|
≥99% |
2756350-98-6 |
5mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
CCR8 antagonist 2
|
C650241-25mg
|
≥99% |
2756350-98-6 |
25mg
|
¥ 11500.9
|
期货,请咨询 |
阿拉丁 |
CCR8 antagonist 2
|
C650241-10mg
|
≥99% |
2756350-98-6 |
10mg
|
¥ 6000.9
|
期货,请咨询 |
阿拉丁 |
Cholesterol sulfate sodium-d7
|
C650215-5mg
|
≥98% |
2687961-01-7 |
5mg
|
¥ 16800.9
|
期货,请咨询 |
阿拉丁 |
Cholesterol sulfate sodium-d7
|
C650215-1mg
|
≥98% |
2687961-01-7 |
1mg
|
¥ 5600.9
|
期货,请咨询 |
阿拉丁 |
CT52923
|
C650187-5mg
|
≥98% |
205256-55-9 |
5mg
|
¥ 900.9
|
期货,请咨询 |
阿拉丁 |
CT52923
|
C650187-50mg
|
≥98% |
205256-55-9 |
50mg
|
¥ 4500.9
|
期货,请咨询 |
阿拉丁 |
CT52923
|
C650187-25mg
|
≥98% |
205256-55-9 |
25mg
|
¥ 2800.9
|
期货,请咨询 |
阿拉丁 |
CT52923
|
C650187-10mg
|
≥98% |
205256-55-9 |
10mg
|
¥ 1400.9
|
期货,请咨询 |
阿拉丁 |
CT52923
|
C650187-100mg
|
≥98% |
205256-55-9 |
100mg
|
¥ 6800.9
|
期货,请咨询 |
阿拉丁 |
CMF019
|
C650180-5mg
|
≥99% |
1586787-08-7 |
5mg
|
¥ 3150.9
|
期货,请咨询 |
阿拉丁 |
CMF019
|
C650180-1mg
|
≥99% |
1586787-08-7 |
1mg
|
¥ 1200.9
|
期货,请咨询 |
阿拉丁 |
CMF019
|
C650180-10mg
|
≥99% |
1586787-08-7 |
10mg
|
¥ 5300.9
|
期货,请咨询 |
阿拉丁 |
2'-C-Methyladenosine
|
C650178-50mg
|
≥99% |
15397-12-3 |
50mg
|
¥ 1800.9
|
期货,请咨询 |
阿拉丁 |
2'-C-Methyladenosine
|
C650178-25mg
|
≥99% |
15397-12-3 |
25mg
|
¥ 1120.9
|
期货,请咨询 |
阿拉丁 |
2'-C-Methyladenosine
|
C650178-10mg
|
≥99% |
15397-12-3 |
10mg
|
¥ 580.9
|
期货,请咨询 |
阿拉丁 |
2'-C-Methyladenosine
|
C650178-100mg
|
≥99% |
15397-12-3 |
100mg
|
¥ 2800.9
|
期货,请咨询 |
阿拉丁 |